Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AceAid Hydrogel is a topical wound dressing developed by AceTech, featuring acemannan as its primary active component. Acemannan is a complex polysaccharide extracted from the inner gel of the *Aloe vera* leaf. The product is formulated as a clear, non-oily, and non-adherent hydrogel designed to manage burns, wounds, and various skin irritations. It functions by creating a protective physical barrier that maintains an optimal moist environment for healing, while also providing a cooling effect to the skin surface and relieving pain. As a naturally derived product free of antibiotics and steroids, it supports tissue regeneration and helps minimize the risk of infection. It is marketed as a CE-marked medical device for indications including superficial diabetic ulcers, foot ulcers, and minor cuts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AceAid Hydrogel.